Everyone's facial tissue structures are unique, including fat distribution, vascular pathways, fascial layers, and muscle morphology. Ultrasound overcomes the limitations of traditional visual inspection and palpation, enabling real-time observation of deep facial tissue structures.
Using high-frequency linear transducers (12–18 MHz) and color Doppler mode, the following structures can be assessed.
Observable Structures
| Tissue Structure | Ultrasound Appearance | Aesthetic Significance |
|---|---|---|
| Epidermis | Continuous hyperechoic line | Assessment of skin surface condition |
| Dermis | Uniform slightly hyperechoic layer | Observation of skin thickness and quality |
| Subcutaneous fat | Hypoechoic area with fibrous septa | Assessment of volume and tissue distribution |
| Fibrous septa | Linear hyperechoic structures | Evaluation of tissue support relationships |
Clinical Applications
Facial rejuvenation is closely related to changes in fat volume. With aging, both superficial and deep fat compartments may undergo atrophy, displacement, or redistribution.
| Type | Primary Regions | Aesthetic Value |
|---|---|---|
| Superficial fat | Nasolabial fat, superficial facial fat | Assessment of superficial volume changes |
| Deep fat | SOOF, deep buccal fat, temporal fat | Support for deep-layer rejuvenation planning |
| Fat septa | Fibrous septa structures | Evaluation of tissue stability |
Clinical Applications
Ultrasound can dynamically visualize facial expression and masticatory muscles, providing precise targeting guidance for botulinum toxin treatments.
| Region | Primary Muscles |
|---|---|
| Forehead | Frontalis |
| Glabella | Corrugator supercilii, procerus |
| Periorbital | Orbicularis oculi |
| Midface | Zygomaticus major, levator labii |
| Lower face | Masseter |
| Temple | Temporalis |
Clinical Value
The facial fascial system is a critical structure for maintaining facial contour.
Observable Structures
Aesthetic Value
Color Doppler ultrasound can visualize important facial vascular structures.
| Vessel | Application Value |
|---|---|
| Facial artery | Risk assessment for nasolabial fold and lower face injections |
| Dorsal nasal artery | Safety assessment for nasal augmentation |
| Angular artery/vein | Risk assessment for periorbital region |
| Supraorbital artery | Risk assessment for forehead and glabella |
| Infraorbital artery | Risk assessment for tear trough and midface |
| Superficial temporal artery | Risk assessment for temple treatments |
Glandular Structures & Applications
Precise Targeting of Target Muscles for Optimized Treatment Outcomes
Ultrasound helps clinicians identify target muscle location, thickness, and surrounding structures, improving injection accuracy and reducing diffusion of the toxin to non-target areas.
| Treatment Area | Target Muscle | Ultrasound Assessment Focus | Clinical Value |
|---|---|---|---|
| Forehead lines | Frontalis | Frontalis appears as a thin hypoechoic structure; assess muscle thickness and depth | Precise dose control, reduce brow abnormalities |
| Glabellar lines | Corrugator supercilii, procerus | Identify muscle location and periosteal relationship | Improve injection accuracy |
| Crow's feet | Orbicularis oculi | Assess muscle thickness and extent | Optimize superficial injection |
| Treatment Area | Target Structure | Ultrasound Assessment Focus | Clinical Value |
|---|---|---|---|
| Masseter hypertrophy | Masseter | Evaluate superficial, middle, and deep layer structure and thickness | Guide precise injection for contour improvement |
| Temporalis hypertrophy | Temporalis | Assess muscle extent and thickness | Optimize temporal contour treatment |
| Facial asymmetry | Expression muscle groups | Dynamic observation of muscle activity | Individualized dosing design |
| Platysma | Platysma | Identify muscle course | Improve neck bands and jawline |
| Treatment Area | Ultrasound Application Value |
|---|---|
| Parotid gland | Define gland extent, assist contour treatment |
| Submandibular gland | Identify gland location, reduce risk of blind injection |
Precise Layer Localization and Vascular Risk Management
Ultrasound-assisted filler treatments focus on:
| Treatment Area | Recommended Injection Layer | Structures of Concern | Ultrasound Value |
|---|---|---|---|
| Forehead | Supraperiosteal, loose connective tissue layer | Supraorbital artery, supratrochlear artery | Plan safe injection pathway |
| Glabella | Subdermal, periosteal layer | Supratrochlear artery | High-risk area assessment |
| Temple | SubSMAS fat layer, periosteal layer | Superficial temporal artery, middle temporal vein | Identify safe layers |
| Tear trough | Subcutaneous, SOOF layer | Angular artery, infraorbital artery | Avoid vascular injury |
| Nasal base | Deep fat layer, periosteal layer | Facial artery branches | Identify vessel location |
| Nose | Supraperiosteal/supraperichondrial | Dorsal nasal artery, intercanthal vessels | Pre-injection risk assessment |
| Nasolabial fold | Multiple layers | Facial artery | Optimize injection path |
| Chin | Supraperiosteal | Local vascular structures | Support contour shaping |
In high-risk regions such as the nose, glabella/forehead, temple and nasolabial fold, ultrasound helps clinicians understand the course of key vessels and select safe injection layers.
| Region | Key Structures | Risks | Ultrasound Value | Recommended Mode |
|---|---|---|---|---|
| Nasal region | Dorsal nasal artery, intercanthal vessels | Vessel injury, embolic risk | Identify vessel course and location | High-frequency ultrasound + color Doppler |
| Glabella and forehead | Supratrochlear artery, supraorbital artery | Intravascular injection risk | Assess vessel depth and pathway | High-frequency ultrasound + color Doppler |
| Temple | Superficial temporal artery, middle temporal vein, deep temporal artery | Vessel injury, incorrect layer placement | Identify fascial layers and safe zones | High-frequency ultrasound + color Doppler |
| Nasolabial fold | Facial artery | Individual variation in vessel course | Individualized vascular localization | High-frequency ultrasound + color Doppler |
Ultrasound can be applied to:
| Filler Material | Ultrasound Appearance | Clinical Significance |
|---|---|---|
| Hyaluronic acid (HA) | Hypoechoic or anechoic mass | Localization and dissolution assessment |
| CaHA | Hyperechoic with acoustic shadowing | Identification of calcium-based fillers |
| PLLA | Punctate hyperechoic | Assess distribution status |
| PCL | Mixed echogenicity | Evaluate material status |
| Autologous fat | Hypoechoic | Assess viability |
| Foreign body material | Hyperechoic or mixed echogenicity | Assist screening |
| Condition | Ultrasound Appearance | Clinical Significance |
|---|---|---|
| Filler migration | Abnormal structures in non-target areas | Guide revision plan |
| Nodule formation | Focal hypoechoic or mixed echogenicity | Determine nature |
| Granuloma | Irregular mixed echogenicity | Assist diagnosis |
| Inflammatory reaction | Tissue thickening with increased vascularity | Assess activity status |
Ultrasound supports objective follow-up of different treatment types after the procedure.
| Treatment Type | Assessment Focus |
|---|---|
| Filler treatment | Material stability, tissue reaction |
| Botulinum toxin | Muscle thickness changes, dynamic activity changes |
| Thread lifting | Thread position, surrounding tissue status |
Facial aging involves:
Ultrasound provides multi-layer analysis:
| Tissue Layer | Assessment Content |
|---|---|
| Skin | Skin thickness and quality |
| Fat layer | Volume changes |
| Fascial layer | Supporting structures |
| Muscle | Dynamic function |